FR2372175A1 - Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17 - Google Patents

Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17

Info

Publication number
FR2372175A1
FR2372175A1 FR7806455A FR7806455A FR2372175A1 FR 2372175 A1 FR2372175 A1 FR 2372175A1 FR 7806455 A FR7806455 A FR 7806455A FR 7806455 A FR7806455 A FR 7806455A FR 2372175 A1 FR2372175 A1 FR 2372175A1
Authority
FR
France
Prior art keywords
hydroxy
androstanone
preparation
androstene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7806455A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2372175A1 publication Critical patent/FR2372175A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procédé de préparation de dérivés de l'androstanone-17 répondant à la formule générale V, dans laquelle la liai
FR7806455A 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17 Pending FR2372175A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
FR2372175A1 true FR2372175A1 (fr) 1978-06-23

Family

ID=5983514

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17

Family Applications Before (3)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17

Country Status (18)

Country Link
US (1) US4179336A (fr)
JP (1) JPS5315493A (fr)
AT (1) AT363196B (fr)
BE (1) BE856860A (fr)
CH (3) CH627190A5 (fr)
CS (1) CS200517B2 (fr)
DD (4) DD136141A5 (fr)
DE (1) DE2632677A1 (fr)
DK (1) DK142372C (fr)
FR (4) FR2365588A1 (fr)
GB (1) GB1585786A (fr)
HU (4) HU179344B (fr)
IE (1) IE45304B1 (fr)
IT (1) IT1077339B (fr)
NL (1) NL7706638A (fr)
SE (1) SE440779B (fr)
SU (1) SU980628A3 (fr)
YU (1) YU164277A (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (fr) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Catalytic Chem Ind Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
EP2644206B1 (fr) * 2003-05-23 2019-04-03 Nektar Therapeutics Derives du PEG qui contiennent deux chaînes de PEG
WO2011053048A2 (fr) * 2009-10-29 2011-05-05 연세대학교 산학협력단 Nouvel inhibiteur de fuite vasculaire
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
CN113234114A (zh) 2011-10-14 2021-08-10 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
RS57390B1 (sr) 2012-12-18 2018-09-28 Univ Washington Neuroaktivni 19-alkoksi-17-supstituisani steroidi, primenjivi u postupcima lečenja
WO2014127201A1 (fr) * 2013-02-15 2014-08-21 Washington University Stéroïdes énantiomères neuroactifs susbtitués en position 15, 16 et 17, utilisés comme modulateurs de récepteurs gaba de type a
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
CN112110976B (zh) 2013-04-17 2023-08-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169831A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
DK3021852T3 (da) 2013-07-19 2021-03-15 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser deraf
WO2015027227A1 (fr) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et utilisations
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SG10202009859YA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
WO2016061537A1 (fr) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions et méthodes pour traiter des troubles du snc
WO2016082789A1 (fr) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions et procédés pour traiter des troubles du snc
EP3250210B1 (fr) 2015-01-26 2020-12-02 Sage Therapeutics, Inc. Compositions et méthodes pour le traitement des troubles du snc
EP4155314A1 (fr) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et leurs utilisations
EP3481844B1 (fr) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c12 et méthodes d'utilisation associées
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
CR20210629A (es) 2019-05-31 2022-03-22 Sage Therapeutics Inc Esteroides neuroactivos y composiciones de estos

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2238220A1 (de) * 1971-08-06 1973-02-15 Searle & Co Verfahren zur herstellung von 3-(3beta, 17beta-dihydroxyandrost-5-en17alpha-yl)-propionsaeure-gamma-lacton

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (fr) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2238220A1 (de) * 1971-08-06 1973-02-15 Searle & Co Verfahren zur herstellung von 3-(3beta, 17beta-dihydroxyandrost-5-en17alpha-yl)-propionsaeure-gamma-lacton

Also Published As

Publication number Publication date
FR2372176A1 (fr) 1978-06-23
HU182789B (en) 1984-03-28
FR2372174A1 (fr) 1978-06-23
DD132439A5 (de) 1978-09-27
AT363196B (de) 1981-07-10
FR2365588B1 (fr) 1982-06-25
HU179344B (en) 1982-10-28
GB1585786A (en) 1981-03-11
BE856860A (fr) 1978-01-16
SU980628A3 (ru) 1982-12-07
NL7706638A (nl) 1978-01-18
SE440779B (sv) 1985-08-19
DE2632677A1 (de) 1978-01-26
DD137235A5 (de) 1979-08-22
IE45304L (en) 1978-01-16
IE45304B1 (en) 1982-07-28
CH629503A5 (de) 1982-04-30
CH627190A5 (fr) 1981-12-31
DK323677A (da) 1978-01-17
SE7708192L (sv) 1978-01-17
CS200517B2 (en) 1980-09-15
US4179336A (en) 1979-12-18
IT1077339B (it) 1985-05-04
DK142372B (da) 1980-10-20
DD136141A5 (de) 1979-06-20
JPS5315493A (en) 1978-02-13
FR2365588A1 (fr) 1978-04-21
YU164277A (en) 1982-08-31
ATA504677A (de) 1980-12-15
JPS6117477B2 (fr) 1986-05-07
HU182790B (en) 1984-03-28
DE2632677C2 (fr) 1988-06-16
CH629222A5 (de) 1982-04-15
DD136142A5 (de) 1979-06-20
DK142372C (da) 1981-03-23
HU182681B (en) 1984-02-28

Similar Documents

Publication Publication Date Title
FR2372175A1 (fr) Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
OA05725A (fr) Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
FR2428052A1 (fr) Nouveaux derives de 5-fluoro-(b-uridine ou 2'-desoxy-b-uridine), procede pour les preparer et agents carcinostatiques les renfermant
FR2386544A1 (fr) Procede pour la preparation de derives d'imidazodiazepine
FR2355797A1 (fr) Procede de preparation de vinylcyclopropanes substitues utilisables dans la preparation d'insecticides
FR2377367A1 (fr) Procede de preparation d'alcoxy-cetones
FR2415097A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur utilisation
FR2370020A2 (fr) Procede de preparation d'alkylphenols
OA06122A (fr) Procédé de préparation d'un nouveau dérivé de pyridine.
FR2354339A1 (fr) Procede de preparation d'acides 1-aminoalcane-1,1-diphosphoniques
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2397387A1 (fr) 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
FR2391204A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur application a la teinture de matieres plastiques
FR2369288A1 (fr) Procede de preparation de composes organiques d'etain
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
FR2374292A1 (fr) Derives de l'acide 2,5-dihydroxybenzoique et applications a titre de medicament
FR2395258A1 (fr) Procede pour la preparation de phenylalkylsulfones
OA06879A (fr) Procédé de préparation de dérivés d'hétéroprostaglandines.
FR2368465A1 (fr) Procede de preparation de dichloronitranilines
FR2366298A1 (fr) Procede de preparation de derives de rifamycine p et q
FR2355811A1 (fr) Preparation de derives cyanes de cyclopropane